United Therapeutics | UTHR - Le Chiffre D'Affaires De Vente





Ventes Changement Date
Amarin USD 49.22M 451K 2025-12
Ardelyx USD 94.47M 30.74M 2026-03
Baxter International USD 2.96B 260M 2026-06
Bayer EUR 10.87B 2.54B 2026-06
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Biogen USD 2.74B 490M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Halozyme Therapeutics USD 481M 104M 2026-06
Insmed USD 425.49M 119.53M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
J&J USD 25.31B 1.21B 2026-06
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Moderna USD 100M 289M 2026-06
Pfizer USD 15.03B 530M 2026-06
PTC Therapeutics USD 361M 88M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Teva Pharmaceutical Industries USD 12.67B 900M 2026-06
United Therapeutics USD 783.3M 1.8M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06